Catalent | CTLT - Ebitda



Ebitda Alterar Data
Agilent USD 456M 84M 2025-12
AstraZeneca USD 5.16B 510M 2026-06
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Bruker USD 110M 101.6M 2026-03
Centene USD 1.55B 1.01B 2026-06
Charles River Laboratories USD 229.8M 28.26M 2026-03
Cigna USD 3.28B 416M 2026-03
Danaher USD 1.84B 81M 2026-06
Dentsply International USD 129M 6M 2026-03
Elevance Health USD 4.21B 2.02B 2026-03
Eli Lilly USD 12.14B 4.26B 2025-12
Glaxosmithkline GBP 2.77B 1.98B 2026-03
Humana USD 2.06B 2.35B 2026-03
Illumina USD 330M 80M 2026-06
Intuitive Surgical USD 1.06B 29.9M 2026-03
IQVIA Holdings USD 994M 62M 2026-06
J&J USD 8.27B 1.08B 2026-03
Laboratory Of America USD 767.7M 162.1M 2026-06
Lonza CHF 1.01B 54M 2025-12
McKesson USD 1.88B 206M 2025-12
Merck EUR 1.53B 87M 2026-03
Merck USD 6.3B 2.09B 2025-12
Mettler Toledo International USD 322.64M 43.66M 2026-06
Novartis USD 6.48B 1.19B 2026-06
Pfizer USD 5.99B 5.23B 2026-03
Quest Diagnostics USD 648M 91M 2026-06
Repligen USD 43.77M 3.76M 2026-06
Revvity USD 272.91M 24M 2026-03
Roche Holding CHF 13.43B 744M 2026-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
Thermo Fisher Scientific USD 3.55B 845M 2026-06
UnitedHealth USD 9.43B 567M 2026-06
Veradigm USD 38.81M 29.61M 2022-09
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 243.6M 17.4M 2026-06